notes
This commit is contained in:
parent
743bb9e76d
commit
7ac8d99278
2 changed files with 17 additions and 0 deletions
|
@ -1,5 +1,20 @@
|
||||||
#+title: Feminizing hormone therapy
|
#+title: Feminizing hormone therapy
|
||||||
|
|
||||||
|
* How should estrogen be administered?
|
||||||
|
|
||||||
|
Options include:
|
||||||
|
- Oral sub-lingual pills
|
||||||
|
- Transdermal patches
|
||||||
|
- Injections
|
||||||
|
|
||||||
|
High-dose oral estradiol carries a higher risk of blood clots; lower-dose
|
||||||
|
transdermal patches may be a preferable option[[file:JerilynnCPrior1968.org][*]].
|
||||||
|
|
||||||
|
* Is Progesterone an important addition to a feminizing HRT regimen?
|
||||||
|
A paper published in [[file:JerilynnCPrior1968.org][The Journal of Clinical Endocrinology & Metabolism by
|
||||||
|
Jerilynn C. Prior]] claims that the addition of progesterone may yield improved
|
||||||
|
feminization and breast development in transgender women.
|
||||||
|
|
||||||
* References
|
* References
|
||||||
- [[file:PrimaryAuthorDr.AmyBournsMDCCFP1963.org][Guidelines for gender-affirming primary care with trans and non-binary
|
- [[file:PrimaryAuthorDr.AmyBournsMDCCFP1963.org][Guidelines for gender-affirming primary care with trans and non-binary
|
||||||
patients]], from Sherbourne Health in Ontario, 2019.
|
patients]], from Sherbourne Health in Ontario, 2019.
|
||||||
|
|
2
JerilynnCPrior1968.org
Normal file
2
JerilynnCPrior1968.org
Normal file
|
@ -0,0 +1,2 @@
|
||||||
|
#+TITLE: Progesterone is important for transgender women’s therapy—applying evidence for the benefits of progesterone in ciswomen
|
||||||
|
#+ROAM_KEY: cite:JerilynnCPrior1968
|
Loading…
Reference in a new issue